HR Execs on the Move

Hikma Pharmaceuticals

www.hikma.com

 
At Hikma we put better health within reach, every day. We create high quality medicines, and we make them accessible and affordable to the people who need them.
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.hikma.com
  • 246 Industrial Way West
    Eatontown, NJ USA 07724
  • Phone: 800.631.2174

Executives

Name Title Contact Details
Sebastian Bova
Global Head of Category Management - R&D Profile
Michael Matchett
Senior Director R&D at Hikma Pharmaceuticals Profile
Sudhir Gorukanti
Vice President, Research & Development Profile
Shahin Fesharaki
Chief Scientific Officer & Global Head of R&D Profile
Saman Mazahreh
Global Head, R&D Project Management Office (PMO) Profile

Similar Companies

Blue Mountain Quality Resources Inc

Blue Mountain Quality Resources Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hanson Research

Hanson Research is a Chatsworth, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rondo-Pak

Rondo-Pak is a global print and packaging specialist providing effective solutions and comprehensive services to the pharmaceutical and life sciences industries. The company`s portfolio of sophisticated packaging solutions addresses precise requirements for compliance, child resistance, anti-counterfeiting e-pedigree and more. Rondo-Pak has been a recognized leader in pharmaceutical folding cartons for over 70 years, and is a proud part of the Körber Medipak network of companies.

DynPort Vaccine Company

DynPort Vaccine Company LLC (DVC) provides an integrated approach for the advanced development of specific vaccines and other products to protect our nation against the threat of bio-warfare agents. This development effort includes process refinement,

BioDelivery Sciences International

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.